Holen Sie sich die Stockscreener-App
17.05
0.41%
0.07
Handel nachbörslich:
17.05
Schlusskurs vom Vortag:
$16.98
Offen:
$17.04
24-Stunden-Volumen:
226.92K
Relative Volume:
0.54
Marktkapitalisierung:
$6.09B
Einnahmen:
$5.21B
Nettoeinkommen (Verlust:
$-211.00M
KGV:
-27.59
EPS:
-0.6179
Netto-Cashflow:
$861.30K
1W Leistung:
+1.61%
1M Leistung:
+6.83%
6M Leistung:
+0.12%
1J Leistung:
+21.09%
1-Tages-Spanne:
$16.91
$17.17
1-Wochen-Bereich:
$16.28
$17.17
52-Wochen-Spanne:
$13.77
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Firmenname
Bausch Lomb Corp
Sektor
Telefon
908-541-5456
Adresse
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
17.05 | 5.99B | 5.21B | -211.00M | 861.30K | -0.6179 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Neutral |
| 2025-05-02 | Bestätigt | H.C. Wainwright | Buy |
| 2025-03-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Eingeleitet | Raymond James | Outperform |
| 2024-05-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Eingeleitet | Stifel | Hold |
| 2023-10-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-06-24 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-06 | Eingeleitet | Citigroup | Buy |
| 2022-05-31 | Eingeleitet | Deutsche Bank | Hold |
| 2022-05-31 | Eingeleitet | Goldman | Neutral |
| 2022-05-31 | Eingeleitet | Guggenheim | Buy |
| 2022-05-31 | Eingeleitet | JP Morgan | Neutral |
| 2022-05-31 | Eingeleitet | Jefferies | Buy |
| 2022-05-31 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-05-11 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Bausch + Lomb Director Robert J. Chersi Granted 11,776 RSUs Under 2022 Incentive Plan - Kalkine Media
Bausch & Lomb (BLCO) director Barbara Trebbi receives 11,776-share RSU award - Stock Titan
Bausch & Lomb (BLCO) files Form 3 for new director Barbara Trebbi - Stock Titan
Bausch & Lomb (BLCO) director awarded 11,776 RSU-based common shares - Stock Titan
Bausch & Lomb (BLCO) director receives 11,776 RSU equity grant as compensation - Stock Titan
Bausch & Lomb Corp (BLCO) adds director Robert J. Chersi in Form 3 filing - Stock Titan
Bausch & Lomb Corp (BLCO) director Thomas Appio reports holding 27,583 shares - stocktitan.net
Why Could Bausch + Lomb (TSX:BLCO) Gain From Aging Demographics? - Kalkine Media
BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure - Stocktwits
Bausch + Lomb (NYSE:BLCO) CAO Sells 52,900 Shares - marketbeat.com
Bausch & Lomb (BLCO) SVP Frederick Munsch sells 52,900 shares in August trade - Stock Titan
Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO? - simplywall.st
Form 8K Bausch & Lomb Corp For: 12 August By Investing.com - Investing.com South Africa
Form 8K Bausch & Lomb Corp For: 12 August - Investing.com India
Bausch & Lomb Corp (BLCO) Director Andrew C. von Eschenbach Sells 18,559 Shares - GuruFocus
BLCO (BLCO) shareholder plans NYSE sale of 52,900 restricted shares - Stock Titan
Bausch + Lomb (NYSE:BLCO) Director Eschenbach Andrew Von Sells 12,500 Shares - marketbeat.com
Bausch & Lomb (NYSE: BLCO) director sells 18,559 shares after board exit - Stock Titan
Insider Selling: Bausch + Lomb (NYSE:BLCO) Director Sells $100,458.22 in Stock - marketbeat.com
BLCO | Bausch + Lomb Corporation FinancialsIncome Statement - Quiver Quantitative
BLCO shareholder plans $887,885 stock sale (NYSE: BLCO) - Stock Titan
Bausch + Lomb Corporation (BLCO): Growth Potential and Analyst Ratings Point to an 11% Upside - DirectorsTalk Interviews
Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - VisionMonday.com
Bausch + Lomb Corporation $BLCO Shares Bought by Sei Investments Co. - marketbeat.com
Bausch + Lomb (BLCO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Bausch Lomb (BLCO) investor plans sale of 12,500 common shares - Stock Titan
Bausch & Lomb Corp (BLCO) awards 16,778 performance-based shares to executive - Stock Titan
Bausch & Lomb (NYSE: BLCO) SVP earns PSUs for 9,091 shares - Stock Titan
Bausch & Lomb Corp (BLCO) EVP awarded 20,973 PSUs after targets met - Stock Titan
Bausch & Lomb (NYSE: BLCO) CFO granted 50,335 performance-linked shares - Stock Titan
Bausch & Lomb (NYSE: BLCO) Surgical president earns 16,778-share PSU-based award - Stock Titan
Bausch & Lomb (NYSE: BLCO) CLO earns 33,557 performance-based shares - Stock Titan
Bausch & Lomb Corp (BLCO) CEO granted 281,879 PSUs tied to 2027 vesting - Stock Titan
Bausch & Lomb Corp SEC Filing (Aug 6, 2026) - Stock Titan
Bausch + Lomb appoints four directors, reaffirms 2026 guidance By Investing.com - Investing.com South Africa
Bausch Health CEO joins Bausch + Lomb board of directors By Investing.com - Investing.com South Africa
Bausch + Lomb Corporation - baystreet.ca
Stocks in play: Bausch + Lomb Corporation - The Globe and Mail
Form 8K Bausch & Lomb Corp For: 6 August By Investing.com - Investing.com Nigeria
Bausch + Lomb Announces Board of Directors Changes, Effective August 5, 2026 - marketscreener.com
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - BioSpace
Bausch + Lomb appoints four directors, reaffirms 2026 guidance - Investing.com
Bausch Health CEO joins Bausch + Lomb board of directors - Investing.com
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PR Newswire
HC Wainwright Reduces Earnings Estimates for Bausch + Lomb - marketbeat.com
Brokers Offer Predictions for Bausch + Lomb Q1 Earnings - marketbeat.com
Bausch + Lomb Introduces New Eyecare Professional Hub - VisionMonday.com
H.C. Wainwright raises Bausch & Lomb stock price target to $21 - Investing.com
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $21 - Moomoo
Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Its 9.65% Potential Upside - DirectorsTalk Interviews
Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):